CHATSWORTH, Calif.--(BUSINESS WIRE)--North American Scientific, Inc. (the “Company”) (Nasdaq: NASM) today announced that it received a letter from The Nasdaq Stock Market (“Nasdaq”) dated May 15, 2008 providing notice that their bid price deficiency has been cured. As a result of regaining compliance with Nasdaq Marketplace Rules, The Nasdaq Listing Qualifications Panel has determined that the hearing scheduled for May 22, 2008 is no longer necessary. The Company’s common stock will continue to be listed on The Nasdaq Capital Market and will continue to trade under the symbol “NASM.”
